ISSN:

Journal Home

Lung Cancer: Targets and Therapy Q2 Unclaimed

Dove Medical Press Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Lung Cancer: Targets and Therapy is a journal indexed in SJR in Oncology with an H index of 20. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on lung cancer, palliative care, cancer screening. It has a best quartile of Q2. It is published in English.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q2)

Price

1602 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

-

SJR Impact factor

20

H Index

14

Total Docs (Last Year)

41

Total Docs (3 years)

893

Total Refs

154

Total Cites (3 years)

41

Citable Docs (3 years)

3.74

Cites/Doc (2 years)

63.79

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Frontiers in Oncology Q2
International Journal of Oncology Q2
Cancer Epidemiology Q2
Translational Lung Cancer Research Q2
Familial Cancer Q2

Compare this journals

Aims and Scope

Lung cancer Palliative care Cancer screening